PT-141 (3mg x 10 Vials = 30mg)

$140.00

PT-141 (Bremelanotide) 10mg is the synthetic cyclic 7-amino-acid melanocortin-receptor agonist with reported preferential MC4R affinity. The deaminated structural analogue of Melanotan II. Supplied lyophilised at greater than 99 percent HPLC purity for in-vitro neuroendocrine research only.

100 in stock

Description

Buy PT-141 (3mg x 10 Vials = 30mg) – Peptide Science

PT-141 (Bremelanotide) 10mg Overview

PT-141 (Bremelanotide) 10mg from Peptide Science is the standard single-vial format of the synthetic cyclic 7-amino-acid melanocortin-receptor agonist, supplied as a lyophilised powder for in-vitro receptor-binding and preclinical neuroendocrine research. The compound is the deaminated analogue of Melanotan II with the C-terminal amide replaced by a hydroxyl group, giving distinct receptor-subtype affinity relative to MT-II.

Compound Class and Mechanism

PT-141 has been characterised in preclinical research for agonist activity at the MC3R and MC4R melanocortin receptors with reported preferential affinity for MC4R, distinguishing it from the broader-spectrum Melanotan II. The compound was originally developed from the synthetic alpha-MSH analogue Melanotan II by structural modification at the C-terminus. Browse the broader melanocortin peptide research range.

Specifications

Property Value
Compound PT-141 (Bremelanotide)
Class Cyclic synthetic melanocortin-receptor agonist
Amino-acid count 7
Molecular weight approximately 1025 g/mol
Supplied form Lyophilised powder, sealed vial
Strength 10 mg per vial
Purity greater than 99 percent (HPLC and mass-spec verified)
Storage 2 to 8 degrees Celsius lyophilised; minus 20 degrees Celsius long-term

For the multi-vial kit format with 10 x 3 mg vials, see PT-141 (3mg x 10 Vials). For the related non-selective melanocortin agonist, see Melanotan II 10mg.

Reconstitution and Handling

The lyophilised vial reconstitutes with bacteriostatic water at the working concentration set by the principal investigator. Aliquoting reconstituted stock for single-use frozen storage is the standard preclinical handling practice cited in peptide-research literature.

Quality and Shipping

Each batch passes HPLC at greater than 99 percent purity, with mass-spectrometry identity confirmation against the theoretical molecular weight. A Certificate of Analysis accompanies every order. Material is filled in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in temperature-monitored insulated packaging via overnight or two-day courier.

For laboratory research and development use only. Not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease or human condition, including sexual dysfunction or pigmentation disorders. Has not been evaluated by the U.S. Food and Drug Administration. Bremelanotide is a prescription-only medicine in the United States when supplied for human therapeutic use under the brand name Vyleesi; research-grade material supplied by Peptide Science is for laboratory work only. The FDA has issued consumer warnings regarding Melanotan II. Purchasers acknowledge they are qualified researchers age 21 or older and accept responsibility for compliance with all applicable federal, state, and local laws.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “PT-141 (3mg x 10 Vials = 30mg)”